Investment Summary |
|
|---|---|
| Date | 2007-03-01 |
| Target | EUSA Pharma |
| Sector | Life Science |
| Investor(s) | EW Healthcare Partners |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
| DEAL STATS | # |
|---|---|
| Overall | 23 of 59 |
| Sector: Life Science M&A | 8 of 20 |
| Type: Growth Capital M&A Deals | 1 of 10 |
| State: Pennsylvania M&A | 4 of 5 |
| Country: United States M&A | 22 of 50 |
| Year: 2007 M&A | 2 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-01-01 |
Oraya Therapeutics
Newark, California, United States Oraya Therapeutics is a privately held, development-stage medical technology company, pioneering noninvasive radiation treatments for inflammatory and neovascular diseases of the eye. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-03-13 |
MediciNova
La Jolla, California, United States MediciNova is a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. MediciNova was founded in 2000 and is based in La Jolla, California. |
Buy | - |
